About this trial
This is a randomized phase II study. Patients will be randomised between current standard of care treatment (Arm 1) vs. omission of radiation to the pathologically node negative dissected hemi-neck(s) (Arm 2) in a 1:2 ratio.
For patients with resected oral cavity squamous cell carcinoma with an indication for post-operative radiation therapy, and at least one pathologically node negative dissected hemi-neck.
Where’s this trial being run?
St Luke’s Radiation Oncology Network @ St Luke’s Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.Print this page
For more detailed informationClick Here
Preservation of Swallowing in Resected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
|Principal Investigator:||Dr Sinéad Brennan|
Dr David Palma, Lawson Health Research Institute
Global: December 2019
Ireland: March 2022
|Global Recruitment Target:||90|
|Ireland Recruitment Target:||24|